Clin2
NCT06960122Likely a fitNot yet recruiting

Fecal transplant for severe diarrhea after pancreas removal

Pancreatic Cancer, ResectedDiarrhea

Treatments studied

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This study tests whether transferring healthy bacteria from donor stool (FMT) into your gut can help control severe diarrhea after total pancreas removal. It may offer a new option when standard treatments haven't worked.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have severe diarrhea after having your whole pancreas removed (total pancreatectomy).
  • You have not taken strong antibiotics (by mouth or IV) in the last 3 days.
  • You can swallow capsules whole.
  • You do not have major organ failure (heart, kidney, or liver), severe infections, or a history of substance abuse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06839599Not yet recruiting· Phase 1/Phase 2
Fecal transplant for chronic diarrhea in adults

This trial tests a new way to give a fecal transplant (called washed microbiota transplantation) to adults with long-term diarrhea. The goal is to see if it helps improve stool consistency and reduce how often you need to go to the bathroom.

Nanjing, Jiangsu
NCT04038619Recruiting· Phase 1
Fecal transplant for immune-therapy diarrhea or bowel inflammation

This early-phase study tests whether stool/fecal microbiota transplant (a fecal transplant) can help people who develop significant diarrhea or colitis after immune-checkpoint therapy. It aims to reduce bowel inflammation and improve symptoms, while carefully checking for infections.

Houston, Texas
NCT06206707Recruiting
FMT for Diarrhea and Colitis After Immunotherapy

This trial tests whether a treatment called fecal microbiota transplant (FMT) — transferring healthy gut bacteria — can help relieve diarrhea and colitis caused by immunotherapy drugs. If you have melanoma or kidney cancer and are experiencing diarrhea after immunotherapy, this study may offer a new option.

Aarhus N
NCT05776914Recruiting· Phase 2
Fecal transplant to treat moderate to severe IBS symptoms

This trial tests whether putting stool (fecal microbiota) from a donor into your bowel can improve symptoms in people with IBS who are not IBS-C. It may help by changing the gut bacteria that can influence IBS symptoms.

Rochester, Minnesota
NCT07153809Recruiting
Fecal transplant for severe acute pancreatitis recovery

This trial tests whether a fecal transplant (transferring healthy gut bacteria from a donor) can help people with severe acute pancreatitis. It is for adults who are about 2 weeks past the onset of the disease and have started to recover but still have fluid buildup in the pancreas.

Shanghai, Shanghai Municipality
NCT06346093Recruiting
Fecal transplant for advanced stomach cancer

This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.

Shanghai, Shanghai Municipality

Hear when a new Diarrhea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.